• Promethera® Announces Initiation of Phase 2b DHELIVER Study of HepaStem™ in Patients with Acute-on-Chronic Liver Failure (ACLF)

    Wednesday January 8th 2020

  • Mithra Signs License and Supply Agreement for Commercialization of Tibelia® in Italy

    Tuesday January 7th 2020

  • Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME

    Tuesday January 7th 2020

  • Mithra Signs LSA with Alvogen for Commercialization of Estelle® in Hong Kong and Taiwan

    Monday January 6th 2020

  • Your news here?

Strategic Partners